Showing posts with label Ezetimibe/simvastatin. Show all posts
Showing posts with label Ezetimibe/simvastatin. Show all posts

Tuesday, January 6, 2015

Cholesterol Drug Vytorin Linked to Reduced Heart Attack Risk



Ezetimibe.pngSimvastatin.svg






We know that, Ezetimibe/simvastatin  is a drug combination used for the treatment of dyslipidemia. It is a combination of ezetimibe (known as Zetia in the United States and Ezetrol elsewhere) and the statin drug simvastatin (known as Zocor in the U.S.). The combination preparation is marketed by Merck & Co. under the trade names Vytorin and InegyEzetimibe reduces blood cholesterol by acting at the brush border of the small intestine and inhibiting the absorption of cholesterol, leading to a decrease in the delivery of intestinal cholesterol to the liver.
Simvastatin is an HMG-CoA reductase inhibitor or statin. It works by blocking an enzyme that is necessary for the body to make cholesterol.